BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 18277153)

  • 1. Cotransporters, WNKs and hypertension: an update.
    Flatman PW
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):186-92. PubMed ID: 18277153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired phosphorylation of Na(+)-K(+)-2Cl(-) cotransporter by oxidative stress-responsive kinase-1 deficiency manifests hypotension and Bartter-like syndrome.
    Lin SH; Yu IS; Jiang ST; Lin SW; Chu P; Chen A; Sytwu HK; Sohara E; Uchida S; Sasaki S; Yang SS
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17538-43. PubMed ID: 21972418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform interactions and activation by T-loop trans-autophosphorylation.
    Thastrup JO; Rafiqi FH; Vitari AC; Pozo-Guisado E; Deak M; Mehellou Y; Alessi DR
    Biochem J; 2012 Jan; 441(1):325-37. PubMed ID: 22032326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interactions of the SPAK/OSR1 kinases with their upstream activator WNK1 and downstream substrate NKCC1.
    Vitari AC; Thastrup J; Rafiqi FH; Deak M; Morrice NA; Karlsson HK; Alessi DR
    Biochem J; 2006 Jul; 397(1):223-31. PubMed ID: 16669787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel Ste20-related proline/alanine-rich kinase (SPAK)-independent pathway involving calcium-binding protein 39 (Cab39) and serine threonine kinase with no lysine member 4 (WNK4) in the activation of Na-K-Cl cotransporters.
    Ponce-Coria J; Markadieu N; Austin TM; Flammang L; Rios K; Welling PA; Delpire E
    J Biol Chem; 2014 Jun; 289(25):17680-8. PubMed ID: 24811174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of heterozygous deletion of WNK1 on the WNK-OSR1/ SPAK-NCC/NKCC1/NKCC2 signal cascade in the kidney and blood vessels.
    Susa K; Kita S; Iwamoto T; Yang SS; Lin SH; Ohta A; Sohara E; Rai T; Sasaki S; Alessi DR; Uchida S
    Clin Exp Nephrol; 2012 Aug; 16(4):530-8. PubMed ID: 22294159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPAK and OSR1 play essential roles in potassium homeostasis through actions on the distal convoluted tubule.
    Ferdaus MZ; Barber KW; López-Cayuqueo KI; Terker AS; Argaiz ER; Gassaway BM; Chambrey R; Gamba G; Rinehart J; McCormick JA
    J Physiol; 2016 Sep; 594(17):4945-66. PubMed ID: 27068441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the WNK-SPAK/OSR1 Pathway and Cation-Chloride Cotransporters for the Therapy of Stroke.
    Josiah SS; Meor Azlan NF; Zhang J
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The WNK-SPAK/OSR1 pathway: master regulator of cation-chloride cotransporters.
    Alessi DR; Zhang J; Khanna A; Hochdörfer T; Shang Y; Kahle KT
    Sci Signal; 2014 Jul; 7(334):re3. PubMed ID: 25028718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of SPAK and OSR1 signalling in the regulation of NaCl cotransporters.
    Mercier-Zuber A; O'Shaughnessy KM
    Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):534-40. PubMed ID: 21610494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the WNK-activated SPAK kinase in regulating blood pressure.
    Rafiqi FH; Zuber AM; Glover M; Richardson C; Fleming S; Jovanović S; Jovanović A; O'Shaughnessy KM; Alessi DR
    EMBO Mol Med; 2010 Feb; 2(2):63-75. PubMed ID: 20091762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of regulation of renal ion transport by WNK kinases.
    Huang CL; Yang SS; Lin SH
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):519-25. PubMed ID: 18695394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylinositol 3-kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in hyperinsulinemic db/db mice.
    Nishida H; Sohara E; Nomura N; Chiga M; Alessi DR; Rai T; Sasaki S; Uchida S
    Hypertension; 2012 Oct; 60(4):981-90. PubMed ID: 22949526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WNK bodies cluster WNK4 and SPAK/OSR1 to promote NCC activation in hypokalemia.
    Thomson MN; Cuevas CA; Bewarder TM; Dittmayer C; Miller LN; Si J; Cornelius RJ; Su XT; Yang CL; McCormick JA; Hadchouel J; Ellison DH; Bachmann S; Mutig K
    Am J Physiol Renal Physiol; 2020 Jan; 318(1):F216-F228. PubMed ID: 31736353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPAK isoforms and OSR1 regulate sodium-chloride co-transporters in a nephron-specific manner.
    Grimm PR; Taneja TK; Liu J; Coleman R; Chen YY; Delpire E; Wade JB; Welling PA
    J Biol Chem; 2012 Nov; 287(45):37673-90. PubMed ID: 22977235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the NKCC2 ion cotransporter by SPAK-OSR1-dependent and -independent pathways.
    Richardson C; Sakamoto K; de los Heros P; Deak M; Campbell DG; Prescott AR; Alessi DR
    J Cell Sci; 2011 Mar; 124(Pt 5):789-800. PubMed ID: 21321328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.
    Ohta A; Schumacher FR; Mehellou Y; Johnson C; Knebel A; Macartney TJ; Wood NT; Alessi DR; Kurz T
    Biochem J; 2013 Apr; 451(1):111-22. PubMed ID: 23387299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1.
    Moriguchi T; Urushiyama S; Hisamoto N; Iemura S; Uchida S; Natsume T; Matsumoto K; Shibuya H
    J Biol Chem; 2005 Dec; 280(52):42685-93. PubMed ID: 16263722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions with WNK (with no lysine) family members regulate oxidative stress response 1 and ion co-transporter activity.
    Sengupta S; Tu SW; Wedin K; Earnest S; Stippec S; Luby-Phelps K; Cobb MH
    J Biol Chem; 2012 Nov; 287(45):37868-79. PubMed ID: 22989884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of NKCC2 activity by inhibitory SPAK isoforms: KS-SPAK is a more potent inhibitor than SPAK2.
    Park HJ; Curry JN; McCormick JA
    Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1687-96. PubMed ID: 24133122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.